Clinical practice guidelines in oncology

Shaji K. Kumar, Natalie S. Callander, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann, Jason C. Chandler, Caitlin Costello, Matthew Faiman, Henry C. Fung, Cristina Gasparetto, Kelly Godby, Craig Hofmeister, Leona Holmberg, Sarah A Holstein, Carol Ann Huff, Adetola Kassim, Michaela Liedtke, Thomas Martin, James Omel, Noopur Raje & 9 others Frederic J. Reu, Seema Singhal, George Somlo, Keith Stockerl-Goldstein, Steven P. Treon, Donna Weber, Joachim Yahalom, D. A. Shead, Rashmi Kumar

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenström's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article.

Original languageEnglish (US)
Pages (from-to)230-269
Number of pages40
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume15
Issue number2
StatePublished - Feb 1 2017

Fingerprint

Multiple Myeloma
Practice Guidelines
Plasma Cells
Waldenstrom Macroglobulinemia
Paraproteinemias
Plasmacytoma
Hypercalcemia
Amyloidosis
Renal Insufficiency
Immunoglobulins
Anemia
Bone Marrow
Guidelines
Light
Infection

ASJC Scopus subject areas

  • Oncology

Cite this

Kumar, S. K., Callander, N. S., Alsina, M., Atanackovic, D., Biermann, J. S., Chandler, J. C., ... Kumar, R. (2017). Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 15(2), 230-269.

Clinical practice guidelines in oncology. / Kumar, Shaji K.; Callander, Natalie S.; Alsina, Melissa; Atanackovic, Djordje; Biermann, J. Sybil; Chandler, Jason C.; Costello, Caitlin; Faiman, Matthew; Fung, Henry C.; Gasparetto, Cristina; Godby, Kelly; Hofmeister, Craig; Holmberg, Leona; Holstein, Sarah A; Huff, Carol Ann; Kassim, Adetola; Liedtke, Michaela; Martin, Thomas; Omel, James; Raje, Noopur; Reu, Frederic J.; Singhal, Seema; Somlo, George; Stockerl-Goldstein, Keith; Treon, Steven P.; Weber, Donna; Yahalom, Joachim; Shead, D. A.; Kumar, Rashmi.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 15, No. 2, 01.02.2017, p. 230-269.

Research output: Contribution to journalArticle

Kumar, SK, Callander, NS, Alsina, M, Atanackovic, D, Biermann, JS, Chandler, JC, Costello, C, Faiman, M, Fung, HC, Gasparetto, C, Godby, K, Hofmeister, C, Holmberg, L, Holstein, SA, Huff, CA, Kassim, A, Liedtke, M, Martin, T, Omel, J, Raje, N, Reu, FJ, Singhal, S, Somlo, G, Stockerl-Goldstein, K, Treon, SP, Weber, D, Yahalom, J, Shead, DA & Kumar, R 2017, 'Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 2, pp. 230-269.
Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Chandler JC et al. Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017 Feb 1;15(2):230-269.
Kumar, Shaji K. ; Callander, Natalie S. ; Alsina, Melissa ; Atanackovic, Djordje ; Biermann, J. Sybil ; Chandler, Jason C. ; Costello, Caitlin ; Faiman, Matthew ; Fung, Henry C. ; Gasparetto, Cristina ; Godby, Kelly ; Hofmeister, Craig ; Holmberg, Leona ; Holstein, Sarah A ; Huff, Carol Ann ; Kassim, Adetola ; Liedtke, Michaela ; Martin, Thomas ; Omel, James ; Raje, Noopur ; Reu, Frederic J. ; Singhal, Seema ; Somlo, George ; Stockerl-Goldstein, Keith ; Treon, Steven P. ; Weber, Donna ; Yahalom, Joachim ; Shead, D. A. ; Kumar, Rashmi. / Clinical practice guidelines in oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2017 ; Vol. 15, No. 2. pp. 230-269.
@article{6518f464296846b1933b1969527957cd,
title = "Clinical practice guidelines in oncology",
abstract = "Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenstr{\"o}m's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article.",
author = "Kumar, {Shaji K.} and Callander, {Natalie S.} and Melissa Alsina and Djordje Atanackovic and Biermann, {J. Sybil} and Chandler, {Jason C.} and Caitlin Costello and Matthew Faiman and Fung, {Henry C.} and Cristina Gasparetto and Kelly Godby and Craig Hofmeister and Leona Holmberg and Holstein, {Sarah A} and Huff, {Carol Ann} and Adetola Kassim and Michaela Liedtke and Thomas Martin and James Omel and Noopur Raje and Reu, {Frederic J.} and Seema Singhal and George Somlo and Keith Stockerl-Goldstein and Treon, {Steven P.} and Donna Weber and Joachim Yahalom and Shead, {D. A.} and Rashmi Kumar",
year = "2017",
month = "2",
day = "1",
language = "English (US)",
volume = "15",
pages = "230--269",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "2",

}

TY - JOUR

T1 - Clinical practice guidelines in oncology

AU - Kumar, Shaji K.

AU - Callander, Natalie S.

AU - Alsina, Melissa

AU - Atanackovic, Djordje

AU - Biermann, J. Sybil

AU - Chandler, Jason C.

AU - Costello, Caitlin

AU - Faiman, Matthew

AU - Fung, Henry C.

AU - Gasparetto, Cristina

AU - Godby, Kelly

AU - Hofmeister, Craig

AU - Holmberg, Leona

AU - Holstein, Sarah A

AU - Huff, Carol Ann

AU - Kassim, Adetola

AU - Liedtke, Michaela

AU - Martin, Thomas

AU - Omel, James

AU - Raje, Noopur

AU - Reu, Frederic J.

AU - Singhal, Seema

AU - Somlo, George

AU - Stockerl-Goldstein, Keith

AU - Treon, Steven P.

AU - Weber, Donna

AU - Yahalom, Joachim

AU - Shead, D. A.

AU - Kumar, Rashmi

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenström's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article.

AB - Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenström's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article.

UR - http://www.scopus.com/inward/record.url?scp=85016214542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016214542&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 230

EP - 269

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 2

ER -